Abstract
Langerhans cells (LC) are dendritic cells present in all squamous epithelia; they are required for antigen presentation and for stimulation of antigen-specific T lymphocyte activation. These cells could play a major role in the local host immune response to human papillomavirus (HPV) infections and in the surveillance against malignant conversion.
The distribution and markers of LC and mononucleated cells of the infiltrate were studied with indirect immunofluorescence method, in a series of benign and malignant papillomas excised from various skin and mucosa sites. They were correlated with the presence of virus group-specific antigen detected by indirect immunofluorescence and typing of viral DNA by DNA-DNA hybridization.
Most of the lesions were characterized by the presence of a mild or a moderate infiltrate of CD4, CD8 and HLA-DR positive cells. The number of LC was reduced in the epithelium of all specimens as compared to the normal epithelia. There was no correlation between the LC density and infecting HPV type. Morphology of LC was also altered with a loss of dendrites.
Epidermal lesions showed a mild inflammatory infiltrate without predominance of either CD4 or CD8-positive cell subsets. On the contrary, mucosal lesions (laryngeal papillomas and CIN) contained a dense infiltrate, with predominance of CD8-positive cells in the epithelium and presence of LC at the junction of epithelium and connective tissue. In some of these lesions HLA-DR antigen was expressed by epithelial cells.
In conclusion, the reduced LC density in HPV-induced lesions is not related to the infecting virus type; it is directly related to the amount of viral infected cells. The exact mechanism of this modification remains unknown; it may be that virus-induced changes in the epithelial microenvironment influence the LC population thereby causing a decrease in the immunological surveillance. Local host tolerance may be induced and thus favor the persistence of the lesions and their conversion towards the malignant state. In this conversion, although LC depletion may be a favoring factor, the association of potentially oncogenic HPV types with other factors remains essential.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beutner, K.R. J. Am. Acad. Dermatol. 20: 114–123, 1989.
Gissmann, L. Cancer Surveys 3: 161–181, 1984.
Orth, G. In: The Papovaviridae N.P. Salzman, P.M. Howley Edit., Plenum Pub. Corp. 2: 199–243, 1987.
Barnett, N., Mak, H. and Winkelstein, J.A. Arch. Dermatol. 119: 5–7, 1983.
Morison, W.L. Brit. J. Dermatol. 93: 553–556, 1975.
Obalek, S., Glinski, W., Haftek, M., Orth, G. and Jablonska, S. Dermatologica 161: 73–83, 1980.
Thivolet, J., Viac, J. and Staquet, M.J.S. Int. J. Dermatol. 21: 94–98, 1982.
Rowden, G. CRC Critical Rev. Immunol. 3: 95–180, 1981.
De Fraissinette, A., Schmitt, D. and Thivolet, J. J. Dermatol. 16: 255–262, 1989.
Thivolet, J. and Schmitt, D. The Langerhans cell. Colloque Inserm/J. Libbey Eurotext Ltd., Paris. 172: 3–490, 1988.
Jenson, A.B., Rosenthal, J.D., Olson, C., Pass, F., Lancaster, W.D. and Shah, K.J. Nat. Cancer Inst. 64: 495–500, 1980.
Chardonnet, Y., Beauve, P., Viac, J. and Schmitt, D. Immunology Letters, 6: 191–196, 1983.
Orth, G., Favre, M., Breitburd, F., Croissant, O., Jablonska, S., Obalek, S., Jarzabek-Chorzelska, M. and Rzesa, G. In: Viruses naturally occurring cancer Cold Spring Harbor Conference on Cell Proliferation 7: 259–282, 1980.
Guérin-Reverchon, I., Chignol, M.C., Chardonnet, Y. and Thivolet, J. J. Imm. Methods. 123: 167–176, 1989.
Chardonnet, Y., Viac, J. and Thivolet, J. Brit. J. Dermatol. 115: 669–675, 1986.
Oguchi, M., Komura, J., Tagami, H. and Ofuji, S. Arch. Dermatol. Res. 270: 403–411, 1981.
Oguchi, M., Komura, J., Tagami, H. and Ofuji, S. Arch. Dermatol. Res. 271: 55–61, 1981.
Tagami, H., Takigawa, M., Ogino, A., Imamura, S. and Ofugi, S. Arch. Dermatol. 113: 1209–1213, 1977.
Tagami, H., Oguchi, M. and Ofuji, S. J. Dermatol. 10: 1–12, 1983.
Iwatsuki, K., Tagami, H., Takigawa, M. and Yamada, M. Arch. Dermatol. 122: 655–659, 1986.
Chardonnet, Y., Viac, J., Levai, J., Bégoud, G., Morgon A. and Thivolet, J. Virchows Arch. (Cell Pathol.) 51: 421–428, 1986.
Viac, J., Chardonnet, Y., Levai, J., Morgon, A., and Thivolet, J. Path. Res. Pract. 182: 157–160, 1987.
Viac, J., Guérin-Reverchon, I., Chardonnet, Y. and Brémond, A. Immunobiology, 1090
Tay, S.K., Jenkins, D., Maddox, P., Campion, M. and Singer, A. Brit. J. Obstet. Gynecol. 94: 10–15, 1987.
Morris, H.H.B., Gatter, K.C., Sykes, G., Casemore, V. and Mason, D.Y. Brit. J. Obst. Gynecol. 90: 412–420, 1983.
Viac, J., Chardonnet, Y., Gilgenkrantz, H., Levai, J. and Thivolet, J. Epithelia 1: 5–16, 1987.
Murphy, G.F., Bhan, A.K., Sato, S., Harrist, T.J. and Mihm, H.C. Lab. Invest. 45: 465–468, 1981.
Liu, H.H., Muller, S.A. and Schroeter, A.L., Acta Derm. Venereol. 67: 411–416, 1987.
Smolle, J., Soyer, H.P., Ehall, R., Bartenstein, S. and Kerl, H. J. Invest. Dermatol. 87: 477–479, 1986.
Gatter, K.C., Morris, H.B., Roach, B., Mortimer, P., Fleming, K.A., and Mason, D.Y. Histopathology 8: 229–244, 1984.
Haftek, M., Jablonska, S., Szymanczyk, J. and Jarzabek-Chorelska, M. Dermatologica 174: 173–179, 1987.
McArdle, J.P., Knight, B.A., Halliday, G.M., Muller, H.K. and Rowden, G. Pathology 18: 212–216, 1986.
Sudo, S., Saito, A. and Morohashi, M. Dermatologica 174: 76–83, 1987.
Becker, J., Behem, J., Löning, T., Reichart, P. and Geerlings, H. Arch. Oral. Biol. 30: 257–264, 1985.
Syrjänen, K.J. Gynecol. Obstet. Invest. 16: 327–340 1983.
Vayrinen, M., Syrjänen, K., Mantyjärvi, R., Castreen, O. and Saarikoski, S. Int. J. Gynaec. Obstet. 22: 375–383, 1984.
Bonnilla-Mussoles, F., Castells, A., Simon, C., Serra V., Pellicer, A., Ramirez, A., and Pardo, G. Eur. J. Gynec. Oncol. 8: 44–61, 1987.
Roncalli, M., Sideri, M., Gie, P. and Servida, E. Lab. Invest. 58: 141–149, 1988.
Alcalay, J., Goldberg, L.H., Wolf, J.E. and Kripke, M.L. Arch. Dermatol. 125: 917–920, 1989.
Stingl, G., Katz, S.I., Clement, L., Green, I. and Shevach, E.M. J. Immunol. 121: 2005–2013, 1978.
Aberer, W., Stingl, G., Stingl-Gasse, L.A., and Wolff, K. J. Invest. Dermatol. 79: 129–135, 1982.
Silberberg, I., Baer, R.L. and Rosenthal, S.A. J. Invest. Dermatol. 66: 210–217, 1976.
Morris, H.H.B., Gatter, K.C., Stein, H. and Mason, D.Y. Brit. J. Obst. Gynecol. 90: 400–411, 1983.
Essman, E.J. and Abramson, A. Int; J. Cancer 33: 33–36, 1984.
Doherty, P.C. Brit. Med. Bull. 41: 7–14, 1985.
Nickoloff, B.J., Basham, T.Y., Merigan, T.C. and Morhenn, V.B. Brit. J. Dermatol. 112: 373–374, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chardonnet, Y., Viac, J. (1991). Warts, Carcinoma and Langerhans Cells. In: Becker, Y. (eds) Skin Langerhans (Dendritic) Cells in Virus Infections and AIDS. Developments in Medical Virology, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3942-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3942-1_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6759-8
Online ISBN: 978-1-4615-3942-1
eBook Packages: Springer Book Archive